After a rigorous peer review process, the board of trustees of Academia Europeae, the pan-European academy of science, humanities and letters, has elected the Stem Cell expert Maria-Elena Torres-Padilla as well as the Epigenetics expert Robert…
Researchers have been able to prove for the first time that activation of distinct human endogenous retroviruses, which are part of our genome, impair brain development dramatically. This finding could help to advance research into therapies for…
A small molecule has entered a novel clinical trial for cancer immunotherapy. The molecule inhibits an enzyme called MALT1 that plays a critical role in suppressing immune reactions against tumor cells. Preclinical studies showed that blocking MALT1…
Researchers at Helmholtz Zentrum München and the University of Bochum received this year's Erwin Schrödinger Prize in recognition of their efforts to develop a cure for parasitic diseases such as Chagas disease with a new compound. The prize is…
Helmholtz Zentrum München is coordinating a European network to train the next generation of researchers in drug development.
Researchers at Helmholtz Zentrum München and Ludwig-Maximilians-University (LMU) mapped the signaling network in plants and discovered novel insights about how plants process information about their environment. This gives new potential to strategies…
We use cookies to improve your experience on our Website. We need cookies to continually improve our services, enable certain features, and when we embed third-party services or content, such as the Vimeo video player or Twitter feeds. In such cases, information may also be transferred to third parties. By using our website, you agree to the use of cookies. We use different types of cookies. You can personalize your cookie settings here:
